Empirical use of imipenem as the sole antibiotic in the treatment of serious infections.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  1985-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JAC/16.4.499PMID 3864777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A randomized study comparing clinical efficacy and safety of thienamycin formamidine (MK0787)/renal dipeptidase inhibitor (MK0791) and cefazolin.

  1983cited by this paper
• Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci

  1983cited by this paper
• Treatment of serious infections with moxalactam.

  1983cited by this paper
• The new beta-lactamase-stable cephalosporins.

  1982cited by this paper
• Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I

  1982cited by this paper
• Comparative In Vitro Activities of N-Formimidoyl Thienamycin and Moxalactam Against Nonfermentative Aerobic Gram-Negative Rods

  1982cited by this paper
• Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability

  1982cited by this paper
• The semi-synthetic thienamycin derivative MK0787 and its properties with respect to a range of beta-lactamases from clinically relevant bacterial species.

  1981cited by this paper
• Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

  1981cited by this paper
• MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities

  1980cited by this paper
• Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics

  1980cited by this paper
• In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin

  1980cited by this paper

• Development of Resistance During Antimicrobial Therapy: A Review of Antibiotic Classes and Patient Characteristics in 173 Studies

  1995cites this paper
• Resistance to Imipenem Among Selected Gram-Negative Bacilli in the United States

  1992cites this paper
• Emergence of imipenem-resistant Pseudomonas aeruginosa during treatment of intra-abdominal infection in a patient with ovarian carcinoma.

  1988cites this paper
• The Efficacy Results and Safety Profile of Imipenem/Cilastatin from the Clinical Research Trials

  1988cites this paper
• Imipenem/Cilastatin: Monotherapy of Hospital Infections

  1987cites this paper
• Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein

  1987cites this paper
• Imipenem (N‐F‐Thienamycin) Versus Netilmicin Plus Clindamycin: A Controlled and Randomized Comparison in Intra‐abdominal Infections

  1987cites this paper
• Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections.

  1987cites this paper
• [Effect and tolerance of daily 2 X 1 g imipenem/cilastatin in general surgery].

  1986cites this paper
• Wirkung und Verträglichkeit von täglich 2×1 g Imipenem/Cilastatin in der Allgemeinchirurgie

  1986cites this paper
• Pathogenesis and treatment of endocarditis.

  1985cites this paper